Pre-clinical Models in Oncology

Making the choice of apt preclinical model considering the similarity to human biology and disease genotypic and phenotypic characters that it carries, marks a considerable potential to ensure higher predictability of preclinical research. The designing and interpretation of trials on human volunteers is a major challenge in the development of novel anticancer agents. Key study design elements like schedule, doses, dose administration, escalation strategy, targeted patient population, etc. rely heavily on preclinical data. This scenario requires cautious decisions on the predictability of preclinical tumor models as well as the method of analysis and translation of the results of preclinical studies. It is surely a challenging task to model for preclinical assessment of cancer immunotherapy, the most actively developing area in oncology. The need for stimulating the response of the immune system adds to the complexity of preclinical models and the applications.

  • Prevent DNA Synthesis
  • Disrupt DNA
  • Protein Inhibitors
  • Interrupt Mitosis
  • Immune System Modifiers
  • Alteration of Protein Function
  • Angiogenesis Inhibitors
  • Differentiating Agents
  • Hormone Function Interference
  • Supporting Agents

Related Conference of Pre-clinical Models in Oncology

December 02, 03, 2019

15th Annual Congress on Pharmacology and Toxicology

Paris, France
February 12-13, 2020

14th Global Pharmacovigilance and Clinical Trials Summit

Sydney, Australia
February 12-13, 2020

2nd International Conference on Biosimilars & Pharmaceuticals

Auckland, New Zealand
March 25-26, 2020

23rd Asia Pacific Pharma Congress

| Singapore
April 01-02, 2020

13th European Biosimilars Congress 2020

London, UK
April 09-10, 2020

World Pharma Expo

Bangkok, Thailand
April 27-28, 2020

5th Pharmaceutical Chemistry Conference

Prague, Czech Republic
April 27-28, 2020

7th European Biopharma Congress

Prague, Czech Republic
May 06-07, 2020

15th Annual Meet on Euro Ethnopharmacology

Prague | Czech Republic
May 18-19, 2020

30th Annual European Pharma Congress

Berlin, Germany
May 27- 28, 2020

14 th World Drug Delivery Summit

| London, UK
June 15-16, 2020

cancer-research-2020

Barcelona, Spain
June 18-19 | 2020

6th World Congress on Medicinal Plants and Marine Drugs

Amsterdam, Netherlands
June 24-25, 2020

25th International Congress on Pharmaceutical Biotechnology

Amsterdam | Netherlands
June 29-30, 2020

12th World Congress on Neuropharmacology

Athens, Greece
August 17-18, 2020

Innovation in Drug Design Techniques and Pharmacology

| Paris, France
August 26-27, 2020

33rdWorld Congress on Pharmacology

Barcelona, Spain
September 07-08, 2020

Global Summit on Generic Drugs and Quality Control

| Prague, Czech Republic
September 10-11, 2020

World Congress on Rare Diseases & Orphan Drugs

| Prague, Czech Republic
September 21-22, 2020

35th World Pharmacology and Toxicology Forum

Tokyo, Japan
November 09-10, 2020

2nd World Congress on Drug Discovery and Drug Design

| Tokyo, Japan
November 09-10, 2020

Annual Meet on Pharmacovigilance & Drug Safety

Tokyo, Japan
November 09-10 , 2020

Asia Pacific Pharmaceutics & Drug Delivery Congress

| Tokyo , Japan
December 02-03, 2020

International Conference onBiotechnology and Healthcare

Auckland, Newzealand
December 06-07, 2021

22nd Pharma Middle East Congress

Dubai, UAE

Pre-clinical Models in Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in